Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
200 employees
Bellevue-based Viome offers nutritional genomics testing, gut flora analysis, and personalized dietary advice.
HQ
Founded
2016
Founded in Bellevue, Washington, Viome is dedicated to revolutionizing health and wellness through nutritional genomics testing and analysis. The company's core mission is to enhance individual health by providing insights into gut flora and other health factors, offering personalized dietary advice based on these insights. Viome's product offerings include comprehensive health solution bundles, custom-formulated supplements, and standalone tests focused on gut, oral, and full-body health.
Notable figures associated with Viome include influential scientists and health experts who contribute to its innovative approach. The company has garnered significant investment from prominent venture capital firms, bolstering its research and development capabilities. Viome's key achievements include pioneering advancements in personalized nutrition and making significant strides in the field of microbiome research. Its impact is evident in the growing consumer awareness and adoption of personalized health solutions, positioning Viome as a leader in the health tech industry.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Supplements, Health Testing
Technology
Analytics, Biotech
Tags
Healthtech
Model Types
Hardware, eCommerce
Revenue Type(s)
Transactional, Recurring
Customer Type(s)
Consumers
Geographic Exposure
United States
When was Viome founded?
Viome was founded in 2016.
Where is Viome's headquarters located?
Viome's headquarters is located in Mountain View, CA, US.
When was Viome's last funding round?
Viome's most recent funding round was for $86.5M (USD) in August 2023.
How many employees does Viome have?
Viome has 200 employees as of Feb 4, 2024.
How much has Viome raised to-date?
As of July 05, 2023, Viome has raised a total of $276M (USD) since Aug 18, 2023.
Add Comparison
Total Raised to Date
$276M
USD
Last Update Aug 18, 2023
Last Deal Details
$86.5M
USD
Aug 18, 2023
Series C
Current Employees
200
Last updated: Feb 4, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts